Nov 18, 2020 / 06:30PM GMT
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity Research
Great. Okay. Well, thanks for joining us. I'm Tim Anderson, the large-cap pharma and biotech analyst at Wolfe Research. And for the next 30 or 35 minutes, we'll be talking with Josh Smiley, who is Senior Vice President and the CFO for Eli Lilly.
Since joining the company in 1995, he's held executive positions across finance and sales and marketing. His experience includes leading U.S. sales and marketing efforts to payers such as managed care organizations and Medicare and Medicaid. We're just going to jump straight into Q&A given the limited time.
Questions and Answers:
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity ResearchHigh-level questions first, just touching on health care reform. I know what the industry wants to see happen, which is things like a lower out-of-pocket spending and that sort of thing. But my question is really trying to understand what's likely to happen as the new administration takes over? So in that sense, asking you to kind of